Skip to main content
Top
Published in: Diagnostic Pathology 1/2012

Open Access 01-12-2012 | Research

Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems

Authors: Yuqing Ma, Qiaoxin Li, Wenli Cui, Na Miao, Xia Liu, Wei Zhang, Chen Zhang, Jian Wang

Published in: Diagnostic Pathology | Issue 1/2012

Login to get access

Abstract

Background

To evaluate the expression and differential significance of c-Jun, p73, Casp-9 and N-ras in thymic epithelial tumors (TETs) with the aim to provide useful information for tumor biology and prospective therapy.

Methods

In this study, we analyzed the expression of four chromosome 1-related genes, namely c-Jun, p73, Casp-9 and N-ras, in 60 cases of thymic epithelial tumors. The tumors included 52 thymomas and 8 thymic carcinomas which were categorized according to the current WHO classification systems.

Results

Compared with the normal thymus tissue, all thymic epithelial tumors demonstrated higher expression of c-Jun and p73. The expression of c-Jun and p73 in type B2, B3 thymoma and thymic carcinomas was similar, and significantly higher than that in all other subtypes of thymomas. Unlike type A thymoma, the expression of Casp-9 was relatively lower in type B thymoma and thymic carcinomas. With respect to the clinical staging systems, c-Jun was more expressed in progressive tumors harboring higher stages. In contrast to c-Jun, p73 and Casp-9, there was no significant aberration with N-ras expression irrespective of either tissue or tumor types.

Conclusions

The overexpression of c-Jun, p73 and Casp-9 in thymic epithelial tumors is closely related with the pathogenesis and biological behavior of the neoplasms. These candidate biomarkers provided useful information for prospective personalized therapy in the clinical management.

Additional non-English language abstract language: Chinese

背景:评估c-Jun, p73, Casp-9 和 N-ras在胸腺上皮性肿瘤诊断和鉴别诊断中的运用.
方法:根据世界卫生组织最新的诊断标准60例胸腺上皮性肿瘤分类,运用Envision法检测c-Jun,p73,Casp-9 和N-ras在不同亚型肿瘤中的表达情况,并结合临床病理学特征进行分析.
结果:c-Jun和p73在肿瘤中的表达明显高于正常胸腺组织;c-Jun和p73在B3,B2型胸腺瘤和胸腺癌的表达类似,且表达明显高于其他类型的胸腺肿瘤;Caspase-9在B型胸腺瘤和胸腺癌中的表达相对低于A型胸腺瘤;c-Jun的表达更常见于高级别的胸腺肿瘤.
结论:c-Jun,p73和Casp-9在胸腺肿瘤中的表达很好地反映了肿瘤的生物学特点,为胸腺肿瘤的诊断和鉴别诊断提供了较好的理论基础.
Appendix
Available only for authorised users
Literature
1.
go back to reference Venuta F, Rendina EA, Anile M, de Giacomo T, Vitolo D, Coloni GF: Thymoma and thymic carcinoma. Gen Thorac Cardiovasc Surg. 2012, 60: 1-12.CrossRefPubMed Venuta F, Rendina EA, Anile M, de Giacomo T, Vitolo D, Coloni GF: Thymoma and thymic carcinoma. Gen Thorac Cardiovasc Surg. 2012, 60: 1-12.CrossRefPubMed
2.
go back to reference Suster S, Moran CA: Thymoma classification: current status and future trends. Am J Clin Pathol. 2006, 125: 542-554.CrossRefPubMed Suster S, Moran CA: Thymoma classification: current status and future trends. Am J Clin Pathol. 2006, 125: 542-554.CrossRefPubMed
3.
go back to reference Chen G, Marx A, Chen WH, Yong J, Puppe B, Stroebel P, Mueller-Hermelink HK: New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer. 2002, 95: 420-429. 10.1002/cncr.10665.CrossRefPubMed Chen G, Marx A, Chen WH, Yong J, Puppe B, Stroebel P, Mueller-Hermelink HK: New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer. 2002, 95: 420-429. 10.1002/cncr.10665.CrossRefPubMed
4.
go back to reference Masaoka A, Monden Y, Nakahara K, Tanioka T: Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981, 48: 2485-2492. 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R.CrossRefPubMed Masaoka A, Monden Y, Nakahara K, Tanioka T: Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981, 48: 2485-2492. 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R.CrossRefPubMed
5.
go back to reference Koga K, Matsuno Y, Noguchi M, Noguchi M, Mukai K, Asamura H, Goya T, Shimosato Y: A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int. 1994, 44: 359-367.CrossRefPubMed Koga K, Matsuno Y, Noguchi M, Noguchi M, Mukai K, Asamura H, Goya T, Shimosato Y: A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int. 1994, 44: 359-367.CrossRefPubMed
6.
go back to reference Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC: World Health organization Classification of Tumours: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. 2004, Lyon, France: IARC Press Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC: World Health organization Classification of Tumours: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. 2004, Lyon, France: IARC Press
7.
go back to reference Rena O, Papalia E, Maggi G, Oliaro A, Ruffini E, Filosso P, Mancuso M, Novero D, Casadio C: World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer. 2005, 50: 59-66. 10.1016/j.lungcan.2005.05.009.CrossRefPubMed Rena O, Papalia E, Maggi G, Oliaro A, Ruffini E, Filosso P, Mancuso M, Novero D, Casadio C: World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer. 2005, 50: 59-66. 10.1016/j.lungcan.2005.05.009.CrossRefPubMed
8.
go back to reference Rea F, Marulli G, Girardi R, Bortolotti L, Favaretto A, Galligioni A, Sartori F: Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg. 2004, 26: 412-418. 10.1016/j.ejcts.2004.04.041.CrossRefPubMed Rea F, Marulli G, Girardi R, Bortolotti L, Favaretto A, Galligioni A, Sartori F: Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg. 2004, 26: 412-418. 10.1016/j.ejcts.2004.04.041.CrossRefPubMed
9.
go back to reference Park MS, Chung KY, Kim KD, Yang WI, Chung JH, Kim YS, Chang J, Kim JH, Kim SK, Kim SK: Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann Thorac Surg. 2004, 78: 992-7. 10.1016/j.athoracsur.2004.03.097. discussion 997–998CrossRefPubMed Park MS, Chung KY, Kim KD, Yang WI, Chung JH, Kim YS, Chang J, Kim JH, Kim SK, Kim SK: Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann Thorac Surg. 2004, 78: 992-7. 10.1016/j.athoracsur.2004.03.097. discussion 997–998CrossRefPubMed
10.
go back to reference Zettl A, Strobel P, Wagner K, Katzenberger T, Ott G, Rosenwald A, Peters K, Krein A, Semik M, Muller-Hermelink HK: Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol. 2000, 157: 257-266. 10.1016/S0002-9440(10)64536-1.PubMedCentralCrossRefPubMed Zettl A, Strobel P, Wagner K, Katzenberger T, Ott G, Rosenwald A, Peters K, Krein A, Semik M, Muller-Hermelink HK: Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol. 2000, 157: 257-266. 10.1016/S0002-9440(10)64536-1.PubMedCentralCrossRefPubMed
11.
go back to reference Ma YQ, Zhang C, Cui WL, Gulinaer A, Zhang W, Wang J: Correlation of amplification of chromosome 1 with histologic typing of thymic epithelial tumors. Zhonghua Bing Li Xue Za Zhi. 2011, 40: 820-824.PubMed Ma YQ, Zhang C, Cui WL, Gulinaer A, Zhang W, Wang J: Correlation of amplification of chromosome 1 with histologic typing of thymic epithelial tumors. Zhonghua Bing Li Xue Za Zhi. 2011, 40: 820-824.PubMed
12.
go back to reference Strobel P, Hohenberger P, Marx A: Thymoma and thymic carcinoma: molecular pathology and targeted therapy. J Thorac Oncol. 2010, 5: S286-S290.CrossRefPubMed Strobel P, Hohenberger P, Marx A: Thymoma and thymic carcinoma: molecular pathology and targeted therapy. J Thorac Oncol. 2010, 5: S286-S290.CrossRefPubMed
13.
go back to reference Li J, Liang X, Yang X: Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-kappaB pathways. Oncol Rep. 2012, 28 (2): 501-510.PubMed Li J, Liang X, Yang X: Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-kappaB pathways. Oncol Rep. 2012, 28 (2): 501-510.PubMed
14.
go back to reference Sui H, Fan ZZ, Li Q: Signal Transduction Pathways and Transcriptional Mechanisms of ABCB1/Pgp-mediated Multiple Drug Resistance in Human Cancer Cells. J Int Med Res. 2012, 40: 426-435.CrossRefPubMed Sui H, Fan ZZ, Li Q: Signal Transduction Pathways and Transcriptional Mechanisms of ABCB1/Pgp-mediated Multiple Drug Resistance in Human Cancer Cells. J Int Med Res. 2012, 40: 426-435.CrossRefPubMed
15.
go back to reference Ye B, Wang X, Yang Z, Sun Z, Zhang R, Hu Y, Lu Y, Du J: p53 and p73 Expression in Esophageal Carcinoma Correlate with Clinicopathology of Tumors. Hepatogastroenterology. 2012, 59: 119- Ye B, Wang X, Yang Z, Sun Z, Zhang R, Hu Y, Lu Y, Du J: p53 and p73 Expression in Esophageal Carcinoma Correlate with Clinicopathology of Tumors. Hepatogastroenterology. 2012, 59: 119-
16.
go back to reference Xu W, Jiang S, Xu Y, Chen B, Li Y, Zong F, Zhao W, Wu J: A meta-analysis of caspase 9 polymorphisms in promoter and exon sequence on cancer susceptibility. PLoS One. 2012, 7: e37443-10.1371/journal.pone.0037443.PubMedCentralCrossRefPubMed Xu W, Jiang S, Xu Y, Chen B, Li Y, Zong F, Zhao W, Wu J: A meta-analysis of caspase 9 polymorphisms in promoter and exon sequence on cancer susceptibility. PLoS One. 2012, 7: e37443-10.1371/journal.pone.0037443.PubMedCentralCrossRefPubMed
17.
go back to reference Kamiya H, Kanno T, Fujita Y, Gotoh A, Nakano T, Nishizaki T: Apoptosis-Related Gene Transcription in Human A549 Lung Cancer Cells via A(3) Adenosine Receptor. Cell Physiol Biochem. 2012, 29: 687-696.CrossRefPubMed Kamiya H, Kanno T, Fujita Y, Gotoh A, Nakano T, Nishizaki T: Apoptosis-Related Gene Transcription in Human A549 Lung Cancer Cells via A(3) Adenosine Receptor. Cell Physiol Biochem. 2012, 29: 687-696.CrossRefPubMed
18.
go back to reference Moran CA, Suster S: Neuroendocrine carcinomas of the thymus (thymic carcinoid): clinicopathologic study of 80 cases with a proposal for histologic grading and clinical staging. Am J Clin Path. 2000, 114: 100-110. 10.1309/3PDN-PMT5-EQTM-H0CD.CrossRefPubMed Moran CA, Suster S: Neuroendocrine carcinomas of the thymus (thymic carcinoid): clinicopathologic study of 80 cases with a proposal for histologic grading and clinical staging. Am J Clin Path. 2000, 114: 100-110. 10.1309/3PDN-PMT5-EQTM-H0CD.CrossRefPubMed
19.
go back to reference Alexiev BA, Drachenberg CB, Burke AP: Thymomas: a cytological and immunohistochemical study,with emphasis on lymphoid and neuroendocrine markers. Diagnostic Pathology. 2007, 2: 13-10.1186/1746-1596-2-13.PubMedCentralCrossRefPubMed Alexiev BA, Drachenberg CB, Burke AP: Thymomas: a cytological and immunohistochemical study,with emphasis on lymphoid and neuroendocrine markers. Diagnostic Pathology. 2007, 2: 13-10.1186/1746-1596-2-13.PubMedCentralCrossRefPubMed
20.
go back to reference Rieker RJ, PhA S, Mechterscheimer G, Thomas M, Dienemann H, Schirmacher P, Kern MA: COX-2 expression in thymomas and thymic carcinomas:a novel therapeutic target?. Diagnostic Pathology. 2007, 2 (suppl I): Rieker RJ, PhA S, Mechterscheimer G, Thomas M, Dienemann H, Schirmacher P, Kern MA: COX-2 expression in thymomas and thymic carcinomas:a novel therapeutic target?. Diagnostic Pathology. 2007, 2 (suppl I):
21.
go back to reference Zhou R, Zettl A, Strobel P, Wagner K, Muller-Hermelink HK, Zhang S, Marx A, Starostik P: Thymic epithelial tumors can develop along two different pathogenetic pathways. Am J Pathol. 2001, 159: 1853-1860. 10.1016/S0002-9440(10)63031-3.PubMedCentralCrossRefPubMed Zhou R, Zettl A, Strobel P, Wagner K, Muller-Hermelink HK, Zhang S, Marx A, Starostik P: Thymic epithelial tumors can develop along two different pathogenetic pathways. Am J Pathol. 2001, 159: 1853-1860. 10.1016/S0002-9440(10)63031-3.PubMedCentralCrossRefPubMed
22.
go back to reference Weber KB, Shroyer KR, Heinz DE, Nawaz S, Said MS, Haugen BR: The use of a combination of Galectin-3, and Thyroid peroxidase for the Diagnosis and Prognosis of Thyroid Cancer. Am J Clin Pathol. 2004, 122: 524-531. 10.1309/UUQTE505PTN5QJ7M.CrossRefPubMed Weber KB, Shroyer KR, Heinz DE, Nawaz S, Said MS, Haugen BR: The use of a combination of Galectin-3, and Thyroid peroxidase for the Diagnosis and Prognosis of Thyroid Cancer. Am J Clin Pathol. 2004, 122: 524-531. 10.1309/UUQTE505PTN5QJ7M.CrossRefPubMed
23.
go back to reference Sasaki H, Ide N, Fukai I, Kiriyama M, Yamakawa Y, Fujii Y: Gene expression analysis of human thymoma correlates with tumor stage. Int J Cancer. 2002, 101: 342-347. 10.1002/ijc.10624.CrossRefPubMed Sasaki H, Ide N, Fukai I, Kiriyama M, Yamakawa Y, Fujii Y: Gene expression analysis of human thymoma correlates with tumor stage. Int J Cancer. 2002, 101: 342-347. 10.1002/ijc.10624.CrossRefPubMed
24.
go back to reference Inoue M, Starostik P, Zettl A, Strobel P, Schwarz S, Scaravilli F, Henry K, Willcox N, Muller-Hermelink HK, Marx A: Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res. 2003, 63: 3708-3715.PubMed Inoue M, Starostik P, Zettl A, Strobel P, Schwarz S, Scaravilli F, Henry K, Willcox N, Muller-Hermelink HK, Marx A: Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res. 2003, 63: 3708-3715.PubMed
25.
go back to reference Penzel R, Hoegel J, Schmitz W, Blaeker H, Morresi-Hauf A, Aulmann S, Hecker E, Mechtersheimer G, Otto HF, Rieker RJ: Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka. Int J Cancer. 2003, 105: 494-498. 10.1002/ijc.11101.CrossRefPubMed Penzel R, Hoegel J, Schmitz W, Blaeker H, Morresi-Hauf A, Aulmann S, Hecker E, Mechtersheimer G, Otto HF, Rieker RJ: Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka. Int J Cancer. 2003, 105: 494-498. 10.1002/ijc.11101.CrossRefPubMed
26.
go back to reference Davies C, Tournier C: Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies. Biochem Soc Trans. 2012, 40: 85-89. 10.1042/BST20110641.CrossRefPubMed Davies C, Tournier C: Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies. Biochem Soc Trans. 2012, 40: 85-89. 10.1042/BST20110641.CrossRefPubMed
27.
go back to reference Sabapathy K: Role of the JNK pathway in human diseases. Prog Mol Biol Transl Sci. 2012, 106: 145-169.CrossRefPubMed Sabapathy K: Role of the JNK pathway in human diseases. Prog Mol Biol Transl Sci. 2012, 106: 145-169.CrossRefPubMed
28.
go back to reference Ma YQ, Miao N, Abulajiang G, Li QX, Liu X, Zhang W, Wang CF, Wang J: Clinicopathologic analysis of 52 cases of thymic epithelial tumor. Zhonghua Bing Li Xue Za Zhi. 2010, 39: 249-254.PubMed Ma YQ, Miao N, Abulajiang G, Li QX, Liu X, Zhang W, Wang CF, Wang J: Clinicopathologic analysis of 52 cases of thymic epithelial tumor. Zhonghua Bing Li Xue Za Zhi. 2010, 39: 249-254.PubMed
29.
go back to reference Kfir S, Ehrlich M, Goldshmid A, Liu X, Kloog Y, Henis YI: Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling. Mol Cell Biol. 2005, 25: 8239-8250. 10.1128/MCB.25.18.8239-8250.2005.PubMedCentralCrossRefPubMed Kfir S, Ehrlich M, Goldshmid A, Liu X, Kloog Y, Henis YI: Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling. Mol Cell Biol. 2005, 25: 8239-8250. 10.1128/MCB.25.18.8239-8250.2005.PubMedCentralCrossRefPubMed
30.
go back to reference Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dorken B, Jenuwein T, Schmitt CA: Oncogene-induced senescence as an initial barrier in lymphoma development. Nature. 2005, 436: 660-665. 10.1038/nature03841.CrossRefPubMed Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dorken B, Jenuwein T, Schmitt CA: Oncogene-induced senescence as an initial barrier in lymphoma development. Nature. 2005, 436: 660-665. 10.1038/nature03841.CrossRefPubMed
31.
go back to reference Wolfman JC, Palmby T, Der CJ, Wolfman A: Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38. Mol Cell Biol. 2002, 22: 1589-1606. 10.1128/MCB.22.5.1589-1606.2002.PubMedCentralCrossRefPubMed Wolfman JC, Palmby T, Der CJ, Wolfman A: Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38. Mol Cell Biol. 2002, 22: 1589-1606. 10.1128/MCB.22.5.1589-1606.2002.PubMedCentralCrossRefPubMed
32.
go back to reference Fu WN, Bertoni F, Kelsey SM, McElwaine SM, Cotter FE, Newland AC, Jia L: Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia. Oncogene. 2003, 22: 451-455. 10.1038/sj.onc.1206147.CrossRefPubMed Fu WN, Bertoni F, Kelsey SM, McElwaine SM, Cotter FE, Newland AC, Jia L: Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia. Oncogene. 2003, 22: 451-455. 10.1038/sj.onc.1206147.CrossRefPubMed
33.
go back to reference Kuwahara D, Tsutsumi K, Kobayashi T, Hyoudou M, Koizuka I: Inhibition of caspase-9 activity in cisplatin-resistant head and neck squamous cell carcinoma. Nihon Jibiinkoka Gakkai Kaiho. 2002, 105: 152-157. 10.3950/jibiinkoka.105.152.CrossRefPubMed Kuwahara D, Tsutsumi K, Kobayashi T, Hyoudou M, Koizuka I: Inhibition of caspase-9 activity in cisplatin-resistant head and neck squamous cell carcinoma. Nihon Jibiinkoka Gakkai Kaiho. 2002, 105: 152-157. 10.3950/jibiinkoka.105.152.CrossRefPubMed
34.
go back to reference Frank O, Brors B, Fabarius A, Li L, Haak M, Merk S, Schwindel U, Zheng C, Muller MC, Gretz N: Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients. Leukemia. 2006, 20: 1400-1407. 10.1038/sj.leu.2404270.CrossRefPubMed Frank O, Brors B, Fabarius A, Li L, Haak M, Merk S, Schwindel U, Zheng C, Muller MC, Gretz N: Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients. Leukemia. 2006, 20: 1400-1407. 10.1038/sj.leu.2404270.CrossRefPubMed
35.
go back to reference Lee KE, Hong YS, Kim BG, Kim NY, Lee KM, Kwak JY, Roh MS: p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival. World J Gastroenterol. 2010, 16: 4448-4454. 10.3748/wjg.v16.i35.4448.PubMedCentralCrossRefPubMed Lee KE, Hong YS, Kim BG, Kim NY, Lee KM, Kwak JY, Roh MS: p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival. World J Gastroenterol. 2010, 16: 4448-4454. 10.3748/wjg.v16.i35.4448.PubMedCentralCrossRefPubMed
36.
go back to reference Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E, Moll UM: DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med. 2002, 196: 765-780. 10.1084/jem.20020179.PubMedCentralCrossRefPubMed Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E, Moll UM: DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med. 2002, 196: 765-780. 10.1084/jem.20020179.PubMedCentralCrossRefPubMed
37.
go back to reference Willis AC, Pipes T, Zhu J, Chen X: p73 can suppress the proliferation of cells that express mutant p53. Oncogene. 2003, 22: 5481-5495. 10.1038/sj.onc.1206505.CrossRefPubMed Willis AC, Pipes T, Zhu J, Chen X: p73 can suppress the proliferation of cells that express mutant p53. Oncogene. 2003, 22: 5481-5495. 10.1038/sj.onc.1206505.CrossRefPubMed
Metadata
Title
Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems
Authors
Yuqing Ma
Qiaoxin Li
Wenli Cui
Na Miao
Xia Liu
Wei Zhang
Chen Zhang
Jian Wang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2012
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-7-120

Other articles of this Issue 1/2012

Diagnostic Pathology 1/2012 Go to the issue